Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): 20-valent pneumococcal conjugate vaccine (PCV20) for children aged 2 through 18 years with underlying medical conditions

    MMWR recomm. rep; 72 (39), 2023
    On June 22, 2023, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended use of 20-valent pneumococcal conjugate vaccine (PCV20 [Prevnar 20, Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.]) as an option to 15-valent pneumococcal conjugate vaccine (PCV15 [Vaxneuvance, Merck Sh...
    Vacuna Neumocócica Conjugada Heptavalente/uso terapéutico, Infecciones Neumocócicas/prevención & control, Inmunogenicidad Vacunal, Comorbilidad
    Texto completo

    Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update

    Tobe, Sheldon; Stone, James; Anderson, Todd; Bacon, Simon; Cheng, Alice; Daskalopoulou, Stella; Ezekpwitz, Justin; Gregoire, Jean; Gubitz, Gord; Jain, Rahul; Keshavjee, Karim; Lindsay, Patty; L’Abbé, Mary; Lau, David C. W; Leiter, Lawrence A; O’Meara, Eileen; Pearson, Glen J; Rabi, Doreen M; Sherifali, Diana; Selby, Peter; Tu, Jack V; Wharton, Sean; Walker, Kimberly M; Hua-Stewart, Diane; Liu, Peter P.
    CMAJ; 190 (40), 2018
    This guideline is directed to primary health care providers caring for Canadian adults who have or are at risk of developing chronic cardiovascular diseases, including hypertension, diabetes, dyslipidemia, heart failure and stroke, and the risk factors for these conditions, including smoking, obesity and...
    Enfermedades Cardiovasculares/prevención & control, Atención Primaria de Salud/normas, Comorbilidad, Enfermedades Cardiovasculares/complicaciones, Factores de Riesgo
    Texto completo